Observational analysis reveals the rapid aggregation of medin amyloid in aging populations, indicating significant mechanistic insights for inhibitors.
Abstract Amyloid deposition is a hallmark of numerous age-related diseases, and understanding the chemical mechanisms that govern amyloid formation is crucial for advancing the rational development of protein aggregation inhibitors. With amyloid formation rates varying widely across proteins, here we report the quantitative aggregation mechanism of medin, the most common localized amyloid in humans, and find it to be extraordinarily faster compared to well-known pathological amyloids such as amyloid-β (Aβ), tau and ⍺-synuclein. Medin, a proteolytic fragment of lactadherin, forms senile localized amyloid deposits in the upper body vasculature of nearly all individuals over 60. We report the microscopic rate constants and reaction orders of medin fibril formation by monitoring the aggregation of recombinant human medin in vitro via a fluorescence-based assay, global kinetic modelling, secondary structure analysis and electron microscopy. Medin spontaneously forms amyloid fibrils at physiological pH and temperature in quiescent solution at concentrations as low as 25 nM, with the highest fibril elongation rate constant when compared to those of Aβ, tau and ⍺-synuclein. Our results identify the microscopic basis of the widespread observation of medin aggregates upon aging, offering a mechanistic starting point for drug discovery to inhibit medin aggregation.
No takes yet. Share an insight, caveat, or question.
Vendruscolo et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: